Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis.
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
Targeting two-pore domain potassium channels - A promising strategy for treating T cell mediated autoimmunity.
Multiple sclerosis and mitochondrial gene variations: A review.
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study.
Galectin-9 is Up-regulated in Astrocytes by TNF and Promotes Encephalitogenic T-cell Apoptosis.
Current and new directions in MRI in multiple sclerosis.
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes-An orchestrated approach.
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.
Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System.
Sphingosine-1 phosphate and central nervous system.
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
Pages
« first
‹ previous
…
503
504
505
506
507
508
509
510
511
…
next ›
last »